A webinar sponsored by Astrix
Presented by: Brendan McCorkle, CEO, SciNote and Luke Cach, Sales Director, Ganymede
Overview:
A key milestone in drug discovery is the successful transition from R&D into manufacturing. Bioprocessing plays a critical role in this journey. As more pharmaceutical companies bring bioprocessing in-house, relying less on external CROs, traditional research or manufacturing-centric electronic lab notebooks (ELNs) are proving inadequate. Bioprocessing demands a flexible, scalable solution that maintains the necessary structure while meeting stringent regulatory requirements. In this webinar, Brendan McCorkle (CEO, SciNote) and Luke Cach (Sales Director, Ganymede) will leverage their experiences in data management and bioprocessing, and discuss how an ELN solution that supports flexible workflows can bridge the gap between R&D and manufacturing. Join us to discover how you can streamline your bioprocessing workflows while ensuring compliance and scalability.
